Osteosarcoma: all 446 studies
Page 3 of 5. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- Inhaled Sargramostim in Treating Patients With First Pulmonary (Lung) Recurrence of OsteosarcomaCompletedNCT00066365Phase 2Results posted
- Exercise Rehabilitation to Improve Long-term Outcomes in Sarcoma Survivors.CompletedNCT07893041Not applicable
- the Exploration of MTAP Deletion in Osteosarcoma by ImmunohistochemistryActive, not recruitingNCT07593573
- Characterization of the Methylation Profile of Stored Human SamplesCompletedNCT07573072
- Single-Patient Expanded Access Protocol - RNA-LP in a Patient With Recurrent OsteosarcomaNo longer availableNCT07560709
- Machine Learning Applied to EHRs Data of Patients With SarcomaCompletedNCT07215728
- Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue SarcomasSuspendedNCT07052383Phase 1
- Study of HS-20093 Versus Gemcitabine in Combination With Docetaxel in Treatment of Osteosarcoma After Previous Second-line Treatment FailureCompletedNCT06935409Phase 3
- Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis AssessmentActive, not recruitingNCT06850506
- Agnostic Therapy in Rare Solid TumorsActive, not recruitingNCT06638931Phase 2
- Intra-arterial Cisplatin Plus Rh-endostatin Combined With Systematic Chemotherapy in OsteosarcomaCompletedNCT06562673Phase 1/2
- Descriptive Cohort of French Patients Treated With Carbonetherapy Since October 2010 Outside PHRC-ETOILECompletedNCT06535997
- A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With CancerActive, not recruitingNCT06521567Phase 1/2
- TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid TumorsTerminatedNCT06438783Phase 1
- Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced CancerActive, not recruitingNCT06416085Phase 2
- Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With OsteosarcomaTerminatedNCT06341712Phase 2
- Oncological and Functional Outcomes in Lower Limb Osteosarcoma Pediatric PatientCompletedNCT06162962
- A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7SuspendedNCT05958199Phase 1
- Retrospective Registry Study of Patients With Cancer Treated With High-dose MethotrexateStatus unknownNCT05899751
- Extracorporeal Shock Wave Therapy on Osteoblast-Like Cells In- Vitro StudyCompletedNCT05801887Not applicable
- 3D Printed Personalized Extendable ProsthesisCompletedNCT05794594
- Quality of Life of Patients With Bone Tumor of the Lower Limbs Treated With Salvage SurgeryCompletedNCT05772312
- Patient's Perception of Exercise After Bone Tumor Resection-A Qualitative StudyStatus unknownNCT05746910
- A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed OsteosarcomaSuspendedNCT05691478Phase 2/3
- Qarziba for Patients in Relapsed/Refractory High-grade OsteosarcomaSuspendedNCT05558280Phase 2
- Efficacy of Tranexamic Acid in Preventing Post Operative Blood Loss in Bone Sarcoma PatientStatus unknownNCT05427513Early Phase 1
- The Effects of Observer Presence and Type on Patients' Perception of Exercise After Bone Tumor Resection-A Qualitative StudyStatus unknownNCT05397522Not applicable
- Regorafenib in Patients With Refractory Primary Bone TumorsCompletedNCT05395741Phase 1/2
- A Phase I Feasibility And Safety Study of Fluorescein-Specific (FITC-E2) CAR T Cells In Combination With Parenterally Administered Folate-Fluorescein (UB-TT170) For Osteogenic SarcomaActive, not recruitingNCT05312411Phase 1
- Neoadjuvant Dual Checkpoint Inhibition and Cryoablation in Relapsed/Refractory Pediatric Solid TumorsCompletedNCT05302921Phase 2
- Apatinib With Ifosfamide Plus Etoposide for Relapsed or Refractory Osteosarcoma (OAIE)CompletedNCT05277480Phase 2
- A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsCompletedNCT05199584Phase 2
- Predictive Models of Treatment Responses and Survival Outcomes in Patients With OsteosarcomaStatus unknownNCT05194605
- Phase 2 Study of 9-ING-41 With Chemotherapy in SarcomaWithdrawnNCT05116800Phase 2
- Integrated Clinical-radiological Analysis of Hypoxia Markers in Pediatric OsteosarcomasStatus unknownNCT05107843
- Construction of Microfluidic Exosome Chip for Diagnosis of Lung Metastasis of OsteosarcomaCompletedNCT05101655
- The Prognostic Value of Serum Biomarkers in OsteosarcomaCompletedNCT05093101
- Long Term Brain Toxicity of Chemotherapy in Patients Treated for a Bone TumorDuring Childhood or AdolescenceCompletedNCT05071001Not applicable
- Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.CompletedNCT05024253Phase 3
- Osteosarcoma Maintenance Therapy With OST31-164Active, not recruitingNCT04974008Phase 2
- Exercise Intervention for Bone Tumor PatientsCompletedNCT04963517Phase 2/3
- Drug Sensitivity and Mutation ProfilingCompletedNCT04956198
- Efficacy of Epidural Analgesia in Lower Extremity OsteosarcomaStatus unknownNCT04945512Not applicable
- A Study to Evaluate the Safety and Efficacy of ALMB-0168 in Patients With OsteosarcomaStatus unknownNCT04886765Phase 1/2
- Gemcitabine With Ascorbate Including AdolescentsWithdrawnNCT04877587Early Phase 1
- Clinical Study of CD276 Targeted Autologous Chimeric Antigen Receptor T Cell Infusion in Patients With CD276 Positive Advanced Solid TumorStatus unknownNCT04864821Early Phase 1
- IBI188 Combination Therapy in Solid TumorsTerminatedNCT04861948Phase 1
- Indo-cyanine Green (ICG) in Paediatric Oncology MISCompletedNCT04854018Phase 4
- A Study of Azenosertib (ZN-c3) in Combination With Gemcitabine in Subjects With OsteosarcomaCompletedNCT04833582Phase 1
- Apatinib Plus IE Chemotherapy (Ifosfamide and Etoposide) for Relapsed or Refractory OsteosarcomaSuspendedNCT04824352Phase 2
- SARC038: Phase 2 Study of Regorafenib and Nivolumab in OsteosarcomaActive, not recruitingNCT04803877Phase 2
- Efficacy of Exercise Program on Osteosarcoma PatientsStatus unknownNCT04757064Not applicable
- TQB3525 for Advanced Bone Sarcomas With PI3KA Mutations or PTEN LossStatus unknownNCT04690725Phase 1/2
- Apatinib + Ifosfamide and Etoposide for Relapsed or Refractory OsteosarcomaCompletedNCT04690231Not applicable
- A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors.Active, not recruitingNCT04671693Not applicable
- Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic SarcomaActive, not recruitingNCT04668300Phase 2
- Cabozantinib With Topotecan-CyclophosphamideCompletedNCT04661852Phase 1
- An Analysis of the Efficacy of High Dose Isofosfamide Through ElastomerCompletedNCT04651569
- Study of Effectiveness of GEMDOX in Relapsed OsteosarcomaCompletedNCT04651179
- Long-term Evaluation of the Quality of Life of Former Patients Treated With Orthopedic Surgery, With or Without RadiotherapyCompletedNCT04644913
- In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid TumorsActive, not recruitingNCT04616248Phase 1
- Osteosarcoma With Resectable Pulmonary Metastasis: A Retrospective StudyCompletedNCT04546243
- Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST TrialSuspendedNCT04539366Phase 1
- B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT04483778Phase 1
- Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMRStatus unknownNCT04461223
- ABCB1/P-glycoprotein Expression Influence on Non-metastatic Osteosarcoma of the ExtremitiesCompletedNCT04383288
- Study of ZKAB001 for Maintenance Therapy in Patients With High-grade Osteosarcoma After Adjuvant ChemotherapyStatus unknownNCT04359550Phase 3
- Comparison of MAPI+Camrelizumab Versus API+Apatinib Versus MAPI in Patients With a Poor Response to Preoperative Chemotherapy for Newly Diagnosed High-grade OsteosarcomaStatus unknownNCT04351308Phase 2
- A Phase I Clinical Trial of Neoadjuvant Chemotherapy With/Without SPIONs/SMF for Patients With OsteosarcomaStatus unknownNCT04316091Phase 1
- Study of Camrelizumab in Combination With Neoadjuvant Chemotherapy in the Treatment of OsteosarcomaStatus unknownNCT04294511Phase 2
- Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity SarcomasCompletedNCT04248959Not applicable
- BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung MetastasesWithdrawnNCT04183062Phase 2
- Indocyanine Green (ICG) Guided Tumor ResectionCompletedNCT04084067Phase 1
- Famitinib Plus Camrelizumab & Famitinib Alone & Famitinib Plus Ifosfamide in Advanced OsteosarcomaWithdrawnNCT04044378Phase 1/2
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Accuracy of Deep-learning Algorithm for Detection and Risk Stratification of Lung NodulesCompletedNCT04022512
- Cancer Genome Study Using Samples From Patients Treated on Clinical Trial SHR1020-SHR-1210-II-OSCompletedNCT03997747
- Glucarpidase After High-Dose Methotrexate in Patients With OsteosarcomaCompletedNCT03960177Early Phase 1
- Zoledronic Acid in Decrease the Lung Metastatic Rate of OsteosarcomaStatus unknownNCT03932071Phase 4
- Proteomics Research of OsteosarcomaStatus unknownNCT03932058
- Epigenetic Biomarker for Advanced Osteosarcoma Using Famitinib and CamrelizumabStatus unknownNCT03919539
- Osteosarcoma in Patients Older Than 40 Years. Prognostic Factors and SurvivalCompletedNCT03911245
- Transcatheter Intra-arterial Limb Infusion of Cisplatin for Extremity OsteosarcomaCompletedNCT03909776Not applicable
- Localized Osteosarcoma in Upper Egypt: A Clinical Prediction ModelCompletedNCT03839095
- Natalizumab in Recurrent, Refractory or Progressive Pulmonary Metastatic OsteosarcomaWithdrawnNCT03811886Phase 1/2
- Inhibition of SENP1 for the Suppression of OS Growth and MetastasisStatus unknownNCT03798587
- an Istitution Experience on Parosteal OsTeosarcomaCompletedNCT03768076
- Pulmonary Resectable Metastases of Osteosarcoma With Anti-angiogenics and CHemotherapyActive, not recruitingNCT03742193Phase 2
- A Clinical Study of PD-L1 Antibody ZKAB001(Drug Code) in Limited Stage of High-grade OsteosarcomaStatus unknownNCT03676985Phase 1/2
- Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma PatientsActive, not recruitingNCT03643133Phase 2
- C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)Active, not recruitingNCT03635632Phase 1
- Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable OsteosarcomaActive, not recruitingNCT03628209Phase 1
- EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT03618381Phase 1
- A Dose Finding Study of CycloSam® Combined With External Beam RadiotherapyWithdrawnNCT03612466Phase 1
- Gemcitabine, Docetaxel, and Hydroxychloroquine in Treating Participants With Recurrent or Refractory OsteosarcomaActive, not recruitingNCT03598595Phase 1/2
- PD-L1 Expression in Advanced OsteosarcomaStatus unknownNCT03582527
- Radiotherapy Concurrent With Apatinib in Advanced Soft Tissue and Bone Sarcomas of Head and Neck--RASS StudyStatus unknownNCT03539172Phase 2
- Biological Characterisation of High Risk CHildhood Cancer in Children, Adolescents and Young Adults (MICCHADO)Active, not recruitingNCT03496402Not applicable
- Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasActive, not recruitingNCT03478462Phase 1
- LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue SarcomasActive, not recruitingNCT03449108Phase 2